Project Grant HT94252510576
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency has awarded a $2,268,386 Project Grant to the Jackson Laboratory in Bar Harbor, Maine to support the research project "Mapping the RNA Splicing Landscape of NF1 and Its Impact on Neurofibromin Function Across Tissues". This 3-year grant, running from August 1, 2025 to July 31, 2028, will fund research aimed at transforming healthcare for military service members, veterans, and the broader public by investigating innovative...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $1,659,679.00 in funding to the University of California, Los Angeles (UCLA) to conduct research targeting heterogeneity in NF2-mutant tumors. The award period runs from September 15, 2024 through September 14, 2027. The key products and services to be delivered under this grant include innovative scientific research, laboratory studies, and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $3,766,416.00 to The Regents of the University of California, San Francisco (UCSF) to conduct advanced biomedical research on expansile duraplasty for the treatment of acute traumatic spinal cord injury. The award has a performance period from July 1, 2025 to June 30, 2029. As a leading academic medical center and research institution, UCSF will leverage...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...